Bio Essence (BIOE) Net Income towards Common Stockholders (2020 - 2026)

Bio Essence's Net Income towards Common Stockholders history runs 7 years deep, the most recent figure standing at $205373.0 for Q1 2026.

• In Q1 2026, Net Income towards Common Stockholders rose 199.82% year-over-year to $205373.0; the TTM figure through Mar 2026 stood at $1.3 million (up 500.31% YoY), while the FY2025 annual figure was $896197.0, up 841.72% from the prior year.
• Net Income towards Common Stockholders was $205373.0 for Q1 2026 at Bio Essence, down from $1.0 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $1.0 million in Q4 2025 to a low of -$633126.0 in Q3 2023.
• Historically, Net Income towards Common Stockholders has averaged $174832.3 across 5 years, with a median of $199233.0 in 2022.
• The sharpest annual moves came in 2022 and 2023: Net Income towards Common Stockholders surged 210.82% in 2022, then slumped 417.78% in 2023.
• A 5-year view of Net Income towards Common Stockholders shows it stood at $213131.0 in 2022, then surged by 192.82% to $624087.0 in 2023, then sank by 119.36% to -$120827.0 in 2024, then jumped by 951.7% to $1.0 million in 2025, then plunged by 80.04% to $205373.0 in 2026.
• The last three Net Income towards Common Stockholders figures came in at $205373.0 (Q1 2026), $1.0 million (Q4 2025), and $12998.0 (Q3 2025), per Business Quant data.